The Evolution of Leadership in POCT
By Kimberly Scott, Clinical Laboratory News, July/August 2019
As point-of-care testing (POCT) continues to grow in hospitals, physician offices, retail clinics, and other settings, professional roles are also evolving to keep pace with changes in this technology, the complexity of testing, and the need to engage with clinicians.
Once consisting of just a handful of assays, POC tests now number in the hundreds, ranging from blood glucose monitoring to rapid strep to prothrombin time/international normalized ratio (PT/INR). The market for POCT grew by an estimated 9.3% between 2013 and 2018, and worldwide, the POCT and rapid diagnostics market is projected to top $38 billion by 2022, according to industry experts.
With the growth of POCT comes challenges for laboratory directors, POC coordinators, and other professionals responsible for ensuring that instruments are maintained and that those performing testing are trained, follow quality control protocols, and remain in compliance with clinical and regulatory standards.
Brenda Suh-Lailam, PhD, DABCC, FAACC, director of clinical chemistry and point-of-care testing at the Ann & Robert H. Lurie Children’s Hospital of Chicago, said much of her time is spent ensuring the quality of testing done at patients’ bedsides by defining, implementing, and monitoring the standards of performance. Read more >